MHRA 2030 Strategy to modernise patient-centred regulation for the era of AI and personalised medicines
Imported from official source
The Medicines and Healthcare products Regulatory Agency (MHRA) has set out ambitious plans to translate cutting-edge scientific and technological innovation into better health outcomes for patients across all four nations of the UK, in its 2030 Strategy published today.
This version
- Version
- 1 of 1
- Recorded
- October 14, 2026 10:00
- Change
- Initial
- Content hash
e834c94ab357a5f145d521b7ab522f1b- All versions
- Revision history